Systematic characterization of tandem repeat variants contributing to complex traits
导致复杂性状的串联重复变异的系统表征
基本信息
- 批准号:10052847
- 负责人:
- 金额:$ 70.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-17 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:Automobile DrivingBioinformaticsBiologicalBiological AssayBipolar DisorderBloodCatalogsClustered Regularly Interspaced Short Palindromic RepeatsComplexCopy Number PolymorphismDNAData SetExhibitsFailureGene ExpressionGene Expression RegulationGenesGenetic VariationGenomeGenomicsGenotypeGenotype-Tissue Expression ProjectHaplotypesHeightHeritabilityHumanHuman GeneticsIn SituIndividualKnowledgeLengthMalariaMedicalMinisatellite RepeatsMolecular BiologyMutationNon-linear ModelsNucleosomesPhenotypePopulationPositioning AttributePublishingRNARNA SplicingRepetitive SequenceReporterResistanceResourcesRoleSNP arraySamplingSchizophreniaShort Tandem RepeatSignal TransductionSingle Nucleotide PolymorphismSourceStructureTandem Repeat SequencesTechniquesTestingTissuesTranscriptVariantbasecancer riskcausal variantexperiencegenetic architecturegenetic variantgenome editinggenome wide association studygenome-widegenomic locusmolecular phenotypenext generation sequencingnovelpredictive teststatisticstechnology developmenttooltraitweb app
项目摘要
SUMMARY ABSTRACT
Genome-wide association studies (GWAS) have identified thousands of genetic loci associated with
complex traits, but determining the causal variants, target genes, and biological mechanisms responsible for
each signal has proven challenging. Furthermore, standard GWAS based on single nucleotide polymorphisms
(SNPs) have been limited by failure to explain the majority of heritability for most traits studied and an inability to
capture multi-allelic variants such as copy number variants (CNVs) and repeats not tagged by SNPs.
We focus on the role of genetic variation at repetitive regions of the genome. Specifically, we consider
two repeat types: short tandem repeats (STRs), consisting of repeated motifs of 1-6bp; and variable number
tandem repeats (VNTRs), with motifs of 7+bp. We collectively refer to STRs and VNTRs as tandem repeats
(TRs). TRs encompass approximately 2 million loci comprising over 3% of the genome. They exhibit rapid
mutation rates and are one of the largest sources of genetic variation. Growing evidence suggests that TRs are
likely to account for part of the “missing heritability” of GWAS. However, due to bioinformatic and experimental
challenges in studying repeats, the genome-wide role of TRs in human traits remains mostly unexplored.
We hypothesize that TR variants are key drivers of complex traits. We recently identified thousands
of STRs predicted to causally regulate gene expression (termed expression STRs, or eSTRs) and revealed that
eSTRs potentially act through a variety of mechanisms including modulating nucleosome positioning and DNA
or RNA secondary structure. We additionally identified specific eSTRs likely underlying published GWAS signals
for height and schizophrenia. Furthermore, other groups have recently discovered TRs as causal drivers of
complex traits including malaria resistance, cancer risk, and bipolar disorder.
While these findings offer intriguing evidence that thousands of TRs contribute to human phenotypes,
they have several limitations. These include: the range of TRs that can be accurately genotyped from next-
generation sequencing (NGS); a lack of sufficiently large NGS datasets for most traits for performing association
analyses; and limited understanding of the potential mechanisms by which TRs participate in gene regulation.
Here, we leverage (i) our recently developed TR genotyping tools and (ii) our published haplotype panel allowing
imputation of TRs into available SNP-array datasets, to systematically evaluate the contribution of TRs to gene
regulation and complex traits in humans. We will first generate a comprehensive catalog of TRs associated with
gene regulation (Aim 1) and establish a framework for validating TR effects using massively parallel reporter
assays and genome editing (Aim 2). We will then impute more than 2 million TRs into large existing GWAS
datasets and perform fine-mapping to identify TRs associated with a range of complex traits and deeply
characterize several TRs predicted to be causal drivers of GWAS signals (Aim 3). This project will fill an
important gap in our knowledge of the genetic architecture of complex traits.
摘要 摘要
全基因组关联研究(GWAS)已经确定了数千个与
复杂的性状,但确定因果变异、目标基因和负责的生物机制
此外,基于单核苷酸多态性的标准 GWAS 已被证明具有挑战性。
(SNP)由于未能解释大多数研究性状的大部分遗传力以及无法解释而受到限制。
捕获多等位基因变异,例如拷贝数变异 (CNV) 和未用 SNP 标记的重复序列。
我们重点关注基因组重复区域的遗传变异的作用,具体而言,我们考虑。
两种重复类型:短串联重复序列 (STR),由 1-6bp 和可变数量的重复基序组成;
串联重复序列(VNTR),具有 7+bp 的基序,我们将 STR 和 VNTR 统称为串联重复序列。
(TR) 包含约 200 万个基因座,占基因组的 3% 以上。
突变率是遗传变异的最大来源之一,越来越多的证据表明 TR 是遗传变异的最大来源之一。
可能是 GWAS 的“遗传性缺失”的一部分,但是,由于生物信息学和实验的原因。
尽管重复研究面临着挑战,但 TR 在人类性状中的全基因组作用仍未得到探索。
我们发现 TR 变异是复杂性状的关键驱动因素,我们最近发现了数千种。
预测会因果调节基因表达的 STR(称为表达 STR 或 eSTR)并揭示
eSTR 可能通过多种机制发挥作用,包括调节核小体定位和 DNA
我们还鉴定了可能发布的 GWAS 信号背后的特定 eSTR。
此外,其他研究小组最近发现TRs是身高和精神分裂症的因果驱动因素。
复杂的特征,包括疟疾抵抗力、癌症风险和双相情感障碍。
虽然这些发现提供了有趣的证据,表明数以千计的 TR 有助于人类表型,
它们有一些局限性,其中包括:可以从下一步准确地进行基因分型的 TR 范围。
世代测序 (NGS);缺乏足够大的 NGS 数据集来进行关联
分析;对 TR 参与基因调控的潜在机制的了解有限。
在这里,我们利用 (i) 我们最近开发的 TR 基因分型工具和 (ii) 我们发布的单倍型面板,允许
将 TR 归入可用的 SNP 阵列数据集中,以系统地评估 TR 对基因的贡献
我们将首先生成与人类相关的 TR 的综合目录。
基因调控(目标 1)并建立使用大规模并行报告基因验证 TR 效应的框架
然后,我们将把超过 200 万个 TR 归入现有的大型 GWAS 中。
数据集并进行精细映射,以识别与一系列复杂特征相关的 TR
描述了预测为 GWAS 信号因果驱动因素的几个 TR(目标 3)。
我们对复杂性状遗传结构的认识存在重大差距。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alon Goren其他文献
Alon Goren的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alon Goren', 18)}}的其他基金
Novel SETD5-based Molecular Mechanisms and Therapeutic Tools to Understand and Revert Neuronal Dysfunction Associated with Intellectual disability and Autism
基于 SETD5 的新型分子机制和治疗工具来理解和恢复与智力障碍和自闭症相关的神经元功能障碍
- 批准号:
10446957 - 财政年份:2022
- 资助金额:
$ 70.5万 - 项目类别:
Novel SETD5-based Molecular Mechanisms and Therapeutic Tools to Understand and Revert Neuronal Dysfunction Associated with Intellectual disability and Autism
基于 SETD5 的新型分子机制和治疗工具来理解和恢复与智力障碍和自闭症相关的神经元功能障碍
- 批准号:
10585929 - 财政年份:2022
- 资助金额:
$ 70.5万 - 项目类别:
Systematic characterization of tandem repeat variants contributing to complex traits
导致复杂性状的串联重复变异的系统表征
- 批准号:
10671075 - 财政年份:2020
- 资助金额:
$ 70.5万 - 项目类别:
Systematic characterization of tandem repeat variants contributing to complex traits
导致复杂性状的串联重复变异的系统表征
- 批准号:
10265508 - 财政年份:2020
- 资助金额:
$ 70.5万 - 项目类别:
Systematic characterization of tandem repeat variants contributing to complex traits
导致复杂性状的串联重复变异的系统表征
- 批准号:
10459499 - 财政年份:2020
- 资助金额:
$ 70.5万 - 项目类别:
Development of a novel method to chart genomic localization of protein complexes in vivo
开发一种绘制蛋白质复合物体内基因组定位图的新方法
- 批准号:
9511383 - 财政年份:2018
- 资助金额:
$ 70.5万 - 项目类别:
Interrogating regulatory variants by multiplexed genome editing
通过多重基因组编辑询问调控变异
- 批准号:
9761568 - 财政年份:2018
- 资助金额:
$ 70.5万 - 项目类别:
相似国自然基金
蛋白质降解决定因子的生物信息学筛选及其耐药突变的多组学分析研究
- 批准号:32300528
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于生物信息学的类风湿性关节炎患者衰弱预测模型的构建与验证
- 批准号:82301786
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于结构表征的蛋白质与长链非编码RNA相互作用预测的生物信息学方法研究
- 批准号:62373216
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
突变和修饰重塑蛋白质亚细胞定位的生物信息学研究
- 批准号:32370698
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
自身免疫性疾病精准诊疗中基于非编码RNA组学和生物信息学的新方法研究
- 批准号:82371855
- 批准年份:2023
- 资助金额:74 万元
- 项目类别:面上项目
相似海外基金
Genetic Architecture of Aging-Related TDP-43 and Mixed Pathology Dementia
衰老相关 TDP-43 和混合病理痴呆的遗传结构
- 批准号:
10658215 - 财政年份:2023
- 资助金额:
$ 70.5万 - 项目类别:
“Pharmacologic targeting of NR4A1 and NR4A2 to activate glioblastoma treatment response”
– NR4A1 和 NR4A2 的药理学靶向激活胶质母细胞瘤治疗反应 –
- 批准号:
10744524 - 财政年份:2023
- 资助金额:
$ 70.5万 - 项目类别:
Dissecting the tumor cell-immune TME axis to identify therapeutically actionable vulnerabilities that potentiate immunotherapy in GBM
剖析肿瘤细胞免疫 TME 轴,以确定可增强 GBM 免疫治疗的治疗上可操作的漏洞
- 批准号:
10743534 - 财政年份:2023
- 资助金额:
$ 70.5万 - 项目类别:
Transposable Elements at the Crossroads of Evolution, Health and Disease
处于进化、健康和疾病十字路口的转座元件
- 批准号:
10750852 - 财政年份:2023
- 资助金额:
$ 70.5万 - 项目类别: